Mirum Pharmaceuticals (MIRM) Net Margin (2021 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly Net Margin came in at 494.21% in Q1 2026, down 48106.0% year-on-year from N/an in Q1 2025, and down 12745.36% quarter-over-quarter from 3.85% in Q4 2025.
Mirum Pharmaceuticals (MIRM) Net Margin (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Net Margin history runs 6 years deep, the most recent figure standing at 494.21% for Q1 2026.
- On a quarterly basis, Net Margin fell 48106.0% year-over-year to 494.21% in Q1 2026; TTM through Mar 2026 was 140.24%, a 11985.0% decrease from a year earlier, with the FY2025 full-year figure at 4.48%, up 2162.0% from the prior year.
- Net Margin eased to 494.21% in Q1 2026 per MIRM's latest filing, from 3.85% in the prior quarter.
- Across five years, Net Margin topped out at 2.18% in Q3 2025 and bottomed at 494.21% in Q1 2026.
- The 5-year median for Net Margin is 49.42% (2023), against an average of 104.33%.
- Biggest YoY gain for Net Margin was 75203 bps in 2022; the steepest drop was 195592 bps in 2022.
- Year by year, Net Margin stood at 130.55% in 2022, then surged by 61 bps to 51.27% in 2023, then soared by 53 bps to 23.93% in 2024, then jumped by 84 bps to 3.85% in 2025, then plunged by 12745 bps to 494.21% in 2026.
- Per Business Quant, the three latest MIRM Net Margin figures stand at 494.21% (Q1 2026), 3.85% (Q4 2025), and 2.18% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -494.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -494.21% |
| Dec 31, 2025 | -3.85% |
| Sep 30, 2025 | 2.18% |
| Jun 30, 2025 | -4.59% |
| Mar 31, 2025 | -13.15% |
| Dec 31, 2024 | -23.93% |
| Sep 30, 2024 | -15.75% |
| Jun 30, 2024 | -31.64% |
| Mar 31, 2024 | -36.52% |
| Dec 31, 2023 | -51.27% |
| Sep 30, 2023 | -49.42% |
| Jun 30, 2023 | -197.45% |
| Mar 31, 2023 | -95.35% |
| Dec 31, 2022 | -130.55% |
| Sep 30, 2022 | -190.13% |
| Jun 30, 2022 | -153.98% |
| Mar 31, 2022 | -283.94% |
| Dec 31, 2021 | 1,825.37% |
| Sep 30, 2021 | -942.16% |
| Jun 30, 2021 | -399.04% |